Structure-based functional analysis of BRCA1 RING domain variants: Concordance of computational mutagenesis,

Majid Masso1, Anirudh Bansal1, Arnav Bansal1

  • 1School of Systems Biology, College of Science, George Mason University, 10900 University Boulevard MS 5B3, Manassas, VA 20110, USA.

Biophysical Chemistry
|September 11, 2020
PubMed

Insights

Interpreting BRCA1 variants of unknown significance is crucial for breast and ovarian cancer treatment. Computational analysis of BRCA1 RING domain variants shows strong concordance with clinical and experimental data, aiding variant classification.

Area of Science:

  • Genetics and Genomics
  • Computational Biology
  • Oncology

Background:

  • Accurate interpretation of BRCA1 variants of unknown significance (VUS) is critical for managing hereditary breast and ovarian cancer (HBOC) risk.
  • Functional assays have quantified the impact of missense mutations on BRCA1's homology-directed DNA repair (HDR) activity, showing high concordance with clinical data.
  • The BRCA1 RING domain is essential for tumor suppression, and its variants are strongly correlated with cancer risk.

Purpose of the Study:

  • To computationally characterize the structural impacts of single residue replacements in the BRCA1 RING domain.
  • To assess the concordance of computational predictions with existing clinical and functional assay data for BRCA1 variants.
  • To develop a complementary computational approach for classifying unexplored BRCA1 RING domain variants.

Main Methods:

  • Implementation of a computational mutagenesis procedure to assess structural impacts of single residue substitutions in the BRCA1 RING domain.
  • Analysis of computational data for concordance with known pathogenic and benign variant clinical classifications.
  • Comparison of computational predictions with experimental data from large-scale functional assays quantifying BRCA1 variant HDR activity.

Main Results:

  • Computational analysis of BRCA1 RING domain variants demonstrated strong concordance with known clinical data.
  • The computational data also showed significant agreement with results from experimental functional assays.
  • Predictions derived from models trained on computational data offer a robust method for variant classification.

Conclusions:

  • Computational mutagenesis provides a reliable and complementary approach to functional assays for interpreting BRCA1 VUS.
  • This method can aid in the classification of all remaining unexplored BRCA1 RING domain variants.
  • Improved variant interpretation will enhance clinical management and genetic counseling for hereditary breast and ovarian cancer.